-
UK vaccine clinical trial outsourcing expansion continues
europeanpharmaceuticalreview
May 05, 2020
An outsourcing company has announced that Phase II, III and IV clinical trials of vaccines will continue at a growing number of sites, assessing the safety of each in light of COVID-19.
-
Shionogi works on Covid-19 therapies and vaccine
pharmaceutical-technology
April 30, 2020
Japanese-based Shionogi has partnered with public institutions, academia and other companies to develop potential drugs and vaccine against Covid-19.
-
IIT Guwahati collaborates with Hester Biosciences to develop vaccine against COVID-19
expresspharma
April 29, 2020
The vaccine will be based on recombinant avian paramyxovirus-based vector platform, the company said.
-
Serum Institute plans to price coronavirus vaccine at ₹1,000 if trials succeed
expresspharma
April 29, 2020
The Serum Institute of India announced that it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.
-
Valo Tx Working to Develop Potential COVID-19 Vaccine
contractpharma
April 28, 2020
Will use PeptiCRAd technology with HLA-matched peptides optimized to further boost CD8+ T-cell immune responses.
-
Plans afoot to develop COVID-19 vaccine at the earliest: Dr Harsh Vardhan
expresspharma
April 27, 2020
Serum Institute of India is collaborating with Oxford University to make the Covid-19 vaccine.
-
HVP Launches Global Initiative to Accelerate the Development of COVID-19 Vaccines
americanpharmaceuticalreview
April 26, 2020
The Human Vaccines Project (HVP), a global nonprofit consortium, is launching the COVID Vaccine Initiative (CVI) to develop safe, effective, accessible vaccines for those most vulnerable to COVID-19.
-
J&J selects Emergent BioSolutions for Covid-19 vaccine manufacturing
pharmaceutical-technology
April 26, 2020
Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutical has signed an agreement with Emergent BioSolutions for manufacturing services for its lead investigational Covid-19 vaccine candidate.
-
China approves third COVID-19 vaccine for clinical trials
expresspharma
April 26, 2020
A total of 96 persons in three age groups have received the vaccine in the first phase of clinical trial as of April 23.
-
Scancell kicks off COVID-19 vaccine development
pharmatimes
April 24, 2020
Scancell has initiated a research programme to develop a vaccine for COVID-19.